Advisory Research’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-56,498
Closed -$5.32M 350
2020
Q4
$5.32M Sell
56,498
-9,625
-15% -$847K 0.39% 78
2020
Q3
$5.72M Buy
66,123
+14,458
+28% +$1.2M 0.56% 60
2020
Q2
$4.17M Sell
51,665
-94,300
-65% -$7.51M 0.37% 77
2020
Q1
$9.59M Buy
+145,965
New +$14M 0.67% 59
2018
Q3
Sell
-2,558
Closed -$277K 370
2018
Q2
$277K Buy
+2,558
New +$275K ﹤0.01% 351
2018
Q1
Sell
-5,678
Closed -$667K 383
2017
Q4
$667K Sell
5,678
-7,770
-58% -$805K 0.01% 302
2017
Q3
$1.33M Buy
13,448
+4,746
+55% +$423K 0.02% 263
2017
Q2
$774K Buy
8,702
+1,931
+29% +$170K 0.01% 335
2017
Q1
$608K Buy
+6,771
New +$584K 0.01% 348

Other funds holding CRI

Advisory Research's CRI Position: Q1 2021 in Review

Advisory Research sold out of Carter's (CRI) in Q1 2021, closing a stake of 56,498 shares — an estimated $5.32M sold.

Advisory Research first reported a position in CRI in Q1 2017 and held it in 9 quarters. The position peaked at $9.59M in Q1 2020. 300 funds tracked by Wall St. Rank hold CRI as of Q1 2021.

  • Advisory Research reported no remaining Carter's position as of Q1 2021 after selling out during the quarter.
  • Advisory Research sold 56,498 Carter's shares in Q1 2021, an estimated $5.32M.
  • Advisory Research first reported a position in Carter's in Q1 2017 and held it in 9 quarters.
  • Advisory Research's Carter's position peaked at $9.59M in Q1 2020.
  • 300 funds tracked by Wall St. Rank held Carter's as of Q1 2021.

Based on Advisory Research's 13F filing for Q1 2021, filed 12 May 2021.